Rompag Eltrombopag Tablets, 50 mg

Product Details

Rompag 50 mg Tablets belongs to the class of 'platelet-stimulating agents' primarily used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Rompag 50 mg Tablets is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused due to hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells. Rompag 50 mg Tablets contains 'Eltrombopag' which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet's production. Rompag 50 mg Tablets works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Rompag 50 mg Tablets helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding. Take Rompag 50 mg Tablets as prescribed by your doctor. In some cases, Rompag 50 mg Tablets can cause common side effects like nausea, diarrhoea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. These side effects are not familiar to everyone who take Rompag 50 mg Tablet 7's and vary individually. If you notice any side effects that are not manageable, please consult your doctor.